Uploaded June 2026 | Updated September 2026, 3 days ago
A major update to the EASD-ADA Consensus Report on Type 1 Diabetes has been unveiled at the 61st EASD Annual Meeting.
In this interview, Prof. Richard Holt and Prof. Kirsten Nørgaard explain the key changes in the updated report and what they mean for clinicians, healthcare systems, policymakers and people living with type 1 diabetes.
The discussion covers the growing role of continuous glucose monitoring (CGM), stronger recommendations for automated insulin delivery systems, and new guidance on obesity management, microvascular complications, and cardiovascular risk factors. The speakers also explain how consensus reports differ from formal clinical guidelines and why they remain an important tool for rapidly translating emerging evidence into practice.
Listen in and subscribe for more.
A major update to the EASD-ADA Consensus Report on Type 1 Diabetes has been unveiled at the 61st EASD Annual Meeting.
In this interview, Prof. Richard Holt and Prof. Kirsten Nørgaard explain the key changes in the updated report and what they mean for clinicians, healthcare systems, policymakers and people living with type 1 diabetes.
The discussion covers the growing role of continuous glucose monitoring (CGM), stronger recommendations for automated insulin delivery systems, and new guidance on obesity management, microvascular complications, and cardiovascular risk factors. The speakers also explain how consensus reports differ from formal clinical guidelines and why they remain an important tool for rapidly translating emerging evidence into practice.
Listen in and subscribe for more.
